Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008;10(3):R57.
doi: 10.1186/ar2426. Epub 2008 May 14.

Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levels

Affiliations
Comparative Study

Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levels

Violet R Mukaro et al. Arthritis Res Ther. 2008.

Abstract

Introduction: While consumption of omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) has been recommended for those at risk of inflammatory disease such as rheumatoid arthritis, the mechanism of their anti-inflammatory effect remains to be clearly defined, particularly in relation to the dose and type of n-3 LCPUFA. The objective of this study was to determine whether varying the levels of n-3 LCPUFA in erythrocyte membrane lipids, following dietary supplementation, is associated with altered numbers and function of circulating leukocytes conducive to protection against inflammation.

Methods: In a double-blind and placebo-controlled study, 44 healthy subjects aged 23 to 63 years consumed either standard or n-3 LCPUFA-enriched versions of typical processed foods, the latter allowing a target daily consumption of 1 gram n-3 LCPUFA. After six months, peripheral blood leukocyte and subpopulation proportions and numbers were assessed by flow cytometry. Leukocytes were also examined for lymphoproliferation and cytokine production, neutrophil chemotaxis, chemokinesis, bactericidal, adherence and iodination activity. Erythrocytes were analyzed for fatty-acid content.

Results: Erythrocyte n-3 LCPUFA levels were higher and absolute leukocyte and lymphocyte numbers were lower in subjects consuming n-3 enriched foods than in controls. There were no changes in the number of neutrophils, monocytes, T cells (CD3+), T-cell subsets (CD4+, CD8+) and B cells (CD19+). However, natural killer (NK) (CD3-CD16+CD56+) cell numbers were lower in n-3 supplemented subjects than in controls and were inversely related to the amount of eicosapentaenoic acid or docosahexaenoic acid in erythrocytes. No significant correlations were found with respect to lymphocyte lymphoproliferation and production of IFN-gamma and IL-2, but lymphotoxin production was higher with greater n-3 LCPUFA membrane content. Similarly, neutrophil chemotaxis, chemokinesis, bactericidal activity and adherence did not vary with changes in erythrocyte n-3 LCPUFA levels, but the iodination reaction was reduced with higher n-3 LCPUFA content.

Conclusion: The data show that regular long-term consumption of n-3 enriched foods leads to lower numbers of NK cells and neutrophil iodination activity but higher lymphotoxin production by lymphocytes. These changes are consistent with decreased inflammatory reaction and tissue damage seen in patients with inflammatory disorders receiving n-3 LCPUFA supplementation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Levels of n-3 fatty acids in membrane phospholipids of erythrocytes. (a) Eicosapentaeonic acid (EPA), (b) docosahexaenoic aid (DHA) and (c) n-3 LCPUFA (EPA + docosapentaenoic acid (DPA) + DHA) in the placebo and supplemented groups. Blood was taken after 6 months and analyzed for fatty-acid composition as outlined in Materials and methods. Data are expressed as mean ± SEM; n = 18 for the placebo group and n = 20 for the supplemented group. ***p < 0.0001, Student t-test.
Figure 2
Figure 2
Effect of n-3 LCPUFA supplementation on leukocyte numbers. Number of (a) total white cells, (b) lymphocytes and (c) NK cells (CD16+CD56+) for the placebo and n-3 supplemented groups. Blood was taken after 6 months and white-cell enumeration carried out as outlined in Materials and methods. Data are expressed as mean ± SEM. *p < 0.05, significance of difference between placebo and supplemented (Student t-test). n = 19 for both placebo and supplemented groups.
Figure 3
Figure 3
Relationship between NK-cell numbers and erythrocyte membrane lipids. (a) Eicosapentaenoic acid (EPA), (b) docosahexaenoic acid (DHA), and (c) total n-3 LCPUFA (EPA + DPA + DHA) after 6 months of supplementation; n = 33. CD16+CD56+, NK cells.
Figure 4
Figure 4
Relationship between PHA-induced proliferation in peripheral blood mononuclear cells and the n-3 LCPUFA content of erythrocyte membranes. Proliferation was measured by incorporation of [3H]thymidine (3H-TdR). There was a significant correlation between [3H]thymidine incoporation and (a) DHA and (b) total n-3 LCPUFA (EPA + DPA + DHA) following a curve (p < 0.05; n = 31).
Figure 5
Figure 5
Effect of n-3 LCPUFA supplementation on the production of lymphotoxin (LT). (a) Peripheral blood mononuclear leukocytes were incubated with PHA and the production of LT was determined after 72 h incubation. *p < 0.05, significance of difference between placebo and supplemented (Student t-test). Data are expressed as mean ± SEM; n = 9 for the placebo group and n = 13 for the supplemented group. (b) Relationship between LT production and erythrocyte membrane eicosapentaenoic acid (EPA) after 6 months supplementation.
Figure 6
Figure 6
Relationship between neutrophil quantitative iodination reaction and the n-3 LCPUFA content of erythrocyte membranes. There was a significant correlation between the iodination activity and (a) EPA and (b) DHA following a curve (p < 0.05; n = 23).

Similar articles

Cited by

References

    1. Kremer JM, Bigauoette J, Michalek AV, Timchalk MA, Lininger L, Rynes RI, Huyck C, Zieminski J, Bartholomew LE. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet. 1985;1:184–187. doi: 10.1016/S0140-6736(85)92024-0. - DOI - PubMed
    1. Donadio JV, Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med. 1994;331:1194–1199. doi: 10.1056/NEJM199411033311804. - DOI - PubMed
    1. Stamp LK, James MJ, Cleland LG. Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum. 2005;35:77–94. doi: 10.1016/j.semarthrit.2005.05.001. - DOI - PubMed
    1. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):1505S–1519S. - PubMed
    1. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–379. doi: 10.1016/S0753-3322(02)00253-6. - DOI - PubMed

Publication types

Substances